ANNA ADAMS: Open Payments
NPI 1407949209 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 25 payments from 13 companies in 2025. Trend: 2023 $1,377 · 2024 $884 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Mindray DS USA, Inc. | 4 | $198 |
| ABBVIE INC. | 7 | $142 |
| Ipsen Biopharmaceuticals, Inc | 1 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $81 |
| Phathom Pharmaceuticals, Inc. | 1 | $61 |
| Novo Nordisk Inc | 2 | $52 |
| QOL Medical, LLC | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| GENZYME CORPORATION | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: PATIENT MONITOR, IQIRVO, TREMFYA, RINVOQ, VOQUEZNA, Wegovy, Sucraid, XIFAXAN.
Industry payments across GA — which companies pay providers there.
